Daniel Passeri
CEO
Board Member
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cue Biopharma, Inc. (CUE) | Former Chief Executive Officer | $240,504 | $1,426,183 |
| 2024 | Cue Biopharma, Inc. (CUE) | Former Chief Executive Officer | $492,910 | $1,393,921 |
| 2023 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $604,824 | $3,015,480 |
| 2022 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $747,507 | $1,373,850 |
| 2021 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $530,974 | $1,820,756 |
| 2020 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $501,154 | $5,841,786 |
| 2019 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $395,000 | $1,198,614 |
| 2018 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $345,000 | $833,858 |
Executive changes
Earnings-call appearances
-
Cue Biopharma, Inc. Q2 FY2024 Earnings Call2024-06-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q4 FY2023 Earnings Call2023-12-31
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q3 FY2023 Earnings Call2023-09-30
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q1 FY2021 Earnings Call2021-03-31
Cue Biopharma, Inc. (CUE)
-
Cue Biopharma, Inc. Q4 FY2020 Earnings Call2020-12-31
Cue Biopharma, Inc. (CUE)